Related Experiment Video
Updated: May 16, 2026

10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
An interpretable, clinically grounded framework for digital speech biomarker development in neurodegenerative
Panying Rong1, Lindsey Heidrick2
1Department of Speech-Language-Hearing: Sciences & Disorders, University of Kansas, Lawrence, KS, United States.
Frontiers in Digital Health
|May 15, 2026
Summary
This study developed an AI-powered speech analysis tool to objectively assess communication decline in neurodegenerative diseases like ALS and Parkinson's, enabling personalized treatment.
Area of Science:
- Neuroscience
- Speech Science
- Artificial Intelligence
Background:
- Communication disorders are common in neurodegenerative diseases, impacting quality of life.
- Current management requires personalized interventions for progressive communication impairments.
- Objective tools for assessing speech changes and variability are needed.
Purpose of the Study:
- To develop an AI-based acoustic framework for automated speech marker extraction.
- To enable objective assessment and phenotyping of communication disorders in neurodegenerative diseases.
- To support personalized, measurement-based care.
Main Methods:
- Analyzed speech samples from individuals with ALS, Parkinson's disease, and healthy controls.
- Extracted 50 acoustic features, clustered into six composite markers.
- Evaluated markers for associations with functional communication, disease differentiation, and phenotyping.
Main Results:
- Markers detected subclinical speech changes before significant functional decline.
- Successfully differentiated disease-specific communication impairments (AUC > 0.90).
- Identified distinct speech subgroups within each disease.
Conclusions:
- The AI framework shows potential for clinical translation.
- Enables early detection, differential diagnosis, and phenotyping of communication disorders.
- Advances personalized care for neurodegenerative diseases.
Keywords:
digital speech markerearly detectionmachine learningneurodegenerative diseasepersonalized medicinephenotypingprogressive communication disorderMore Related Videos
Related Concept Videos
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

